The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection
Open accessPublished version of a preprint
Abstract
MicroRNAs (miRNAs) are post-transcriptional regulators of gene expression found in more than 200 diverse organisms. Although it is still not fully established if RNA viruses could generate miRNAs, there are examples of miRNA like sequences from RNA viruses with regulatory functions. In the case of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), there are several mechanisms that would make miRNAs impact the virus, like interfering with viral replication, translation and even modulating the host expression. In this study, we performed a machine learning based miRNA prediction analysis for the SARS-CoV-2 genome to identify miRNA-like hairpins and searched for potential miRNA-based interactions between the viral miRNAs and human genes and human miRNAs and viral genes. Overall, 950 hairpin structured sequences were extracted from the virus genome and based on the prediction results, 29 of them could be precursor miRNAs. Targeting analysis showed that 30 viral mature miRNA-like sequences could target 1,367 different human genes. PANTHER gene function analysis results indicated that viral derived miRNA candidates could target various human genes involved in crucial cellular processes including transcription, metabolism, defense system and several signaling pathways such as Wnt and EGFR signalings. Protein class-based grouping of targeted human genes showed that host transcription might be one of the main targets of the virus since 96 genes involved in transcriptional processes were potential targets of predicted viral miRNAs. For instance, basal transcription machinery elements including several components of human mediator complex (MED1, MED9, MED12L, MED19), basal transcription factors such as TAF4, TAF5, TAF7L and site-specific transcription factors such as STAT1 were found to be targeted. In addition, many known human miRNAs appeared to be able to target viral genes involved in viral life cycle such as S, M, N, E proteins and ORF1ab, ORF3a, ORF8, ORF7a and ORF10. Considering the fact that miRNA-based therapies have been paid attention, based on the findings of this study, comprehending mode of actions of miRNAs and their possible roles during SARS-CoV-2 infections could create new opportunities for the development and improvement of new therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Learning can help to realize potential miRNA-based interactions between the viral miRNAs and human genes as well as human miRNAs and viral genes, which are important to identify the mechanisms behind the SARS-CoV-2 infections.”
From Blockchain and AI-Based Solutions to Combat Coronavirus (COVID-19)-Like Epidemics: A Survey (2021) · cites this paper as [117]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
miRBase: tools for microRNA genomics
Griffiths‐Jones, S., Saini, H. K., van Dongen, S., & Enright, A. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm952 · Cited by 4,432
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
miRBase: integrating microRNA annotation and deep-sequencing data
Kozomara, A., & Griffiths-Jones, S. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1027 · Cited by 3,634
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Chen, Y. Z., Liu, Q., & Guo, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25681 · Cited by 3,069
Vienna RNA secondary structure server
Hofacker, I. L. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg599 · Cited by 2,362
Xu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., Zhong, W., & Hao, P. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1637-5 · Cited by 2,202
psRNATarget: a plant small RNA target analysis server
Dai, X., & Zhao, P. X. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr319 · Cited by 1,847
The Molecular Biology of Coronaviruses
Masters, P. S. (2006) · Advances in virus research · doi:10.1016/s0065-3527(06)66005-3 · Cited by 1,806
Mi, H., Muruganujan, A., & Thomas, P. D. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1118 · Cited by 1,739
Identification of Virus-Encoded MicroRNAs
Pfeffer, S., Zavolan, M., Grässer, F., Chien, M.-C., Russo, J., Ju, J.-Y., John, B., Enright, A., Marks, D., Sander, C., et al. (2004) · Science · doi:10.1126/science.1096781 · Cited by 1,708
KNIME: The Konstanz Information Miner
Berthold, M., Cebron, N., Dill, F., Gabriel, T. R., Kötter, T., Meinl, T., Ohl, P., Sieb, C., Thiel, K., & Wiswedel, B. (2007) · Annual Conference of the Gesellschaft für Klassifikation · doi:10.1007/978-3-540-78246-9_38 · Cited by 1,539
A structural analysis of M protein in coronavirus assembly and morphology
Neuman, B. W., Kiss, G., Kunding, A. H., Bhella, D., Baksh, M. F., Connelly, S., Droese, B., Klaus, J. P., Makino, S., Sawicki, S. G., et al. (2010) · Journal of Structural Biology · doi:10.1016/j.jsb.2010.11.021 · Cited by 870
Paraskevis, D. N., Kostaki, E. G., Magiorkinis, G., Panayiotakopoulos, G., Sourvinos, G., & Tsiodras, S. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104212 · Cited by 769
Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China
Deng, S., & Peng, H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020575 · Cited by 756
Coronavirus Disease 2019: Coronaviruses and Blood Safety
Chang, L., Yan, Y., & Wang, L. (2020) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2020.02.003 · Cited by 674
Coronavirus Spike Proteins in Viral Entry and Pathogenesis
Gallagher, T. M., & Buchmeier, M. J. (2001) · Virology · doi:10.1006/viro.2000.0757 · Cited by 658
2019 Novel coronavirus: where we are and what we know
Cheng, Z. J., & Shan, J. (2020) · Infection · doi:10.1007/s15010-020-01401-y · Cited by 656
Host Factors in Coronavirus Replication
de Wilde, A. H., Snijder, E. J., Kikkert, M., & van Hemert, M. J. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_25 · Cited by 554
Frieman, M. B., Yount, B. L., Heise, M. T., Kopecky-Bromberg, S. A., Palese, P., & Baric, R. S. (2007) · Journal of Virology · doi:10.1128/jvi.01012-07 · Cited by 509
MicroRNA Regulation of RNA Virus Replication and Pathogenesis
Trobaugh, D. W., & Klimstra, W. B. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.11.003 · Cited by 396
Castaño-Rodríguez, C., Honrubia, J. M., Gutierrez-Alvarez, F. J., DeDiego, M. L., Nieto-Torres, J. L., Jiménez-Guardeño, J. M., Regla-Nava, J. Á., Fernández‐Delgado, R., Verdiá-Báguena, C., Queralt-Martín, M., et al. (2018) · mBio · doi:10.1128/mbio.02325-17 · Cited by 317
SARS coronavirus E protein forms cation-selective ion channels
Wilson, L., Mckinlay, C., Gage, P. W., & Ewart, G. D. (2004) · Virology · doi:10.1016/j.virol.2004.09.033 · Cited by 292
van der Ree, M. H., de Vree, J. M., Stelma, F., Willemse, S. B., van der Valk, M., Rietdijk, S. T., Molenkamp, R., Schinkel, J., van Nuenen, A. C., Beuers, U. H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31715-9 · Cited by 271
MicroRNA Therapeutics: the Next Magic Bullet?
Simonson, B., & Das, S. (2015) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557515666150324123208 · Cited by 266
Viruses and miRNAs: More Friends than Foes
Bruscella, P., Bottini, S., Baudesson, C., Pawlotsky, J., Féray, C., & Trabucchi, M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00824 · Cited by 209
Cellular versus viral microRNAs in host-virus interaction
Ghosh, Z., Mallick, B., & Chakrabarti, J. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn1004 · Cited by 203
Lau, S. K. P., Feng, Y., Chen, H., Luk, H. K. H., Yang, W.-H., Li, K. S. M., Zhang, Y.-Z., Huang, Y. P., Song, Z.-Z., Chow, F. W., et al. (2015) · Journal of Virology · doi:10.1128/jvi.01048-15 · Cited by 191
Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis
Khatun, M., & Ray, R. B. (2019) · Cells · doi:10.3390/cells8101249 · Cited by 187
Cytopathogenesis and Inhibition of Host Gene Expression by RNA Viruses
Lyles, D. S. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.4.709-724.2000 · Cited by 178
The Interplay Between Viral-Derived miRNAs and Host Immunity During Infection
Mishra, R., Kumar, A., Ingle, H., & Kumar, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03079 · Cited by 172
HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression
Klase, Z. A., Winograd, R., Davis, J., Carpio, L., Hildreth, R. L., Heydarian, M., Fu, S. W., McCaffrey, T. A., Meiri, E., Ayash‐Rashkovsky, M., et al. (2009) · Retrovirology · doi:10.1186/1742-4690-6-18 · Cited by 166
The Role of microRNAs in the Pathogenesis of Herpesvirus Infection
Piedade, D., & Azevedo‐Pereira, J. M. (2016) · Viruses · doi:10.3390/v8060156 · Cited by 163
SARS coronavirus replicase proteins in pathogenesis
Graham, R. L., Sparks, J. S., Eckerle, L. D., Sims, A. M., & Denison, M. R. (2007) · Virus Research · doi:10.1016/j.virusres.2007.02.017 · Cited by 154
Tan, Y.-X., Tan, T. H. P., Lee, M. J.-R., Tham, P.-Y., Gunalan, V., Druce, J. D., Birch, C. J., Catton, M. G., Fu, N. Y., Yu, V. C. K., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00090-07 · Cited by 133
MicroRNome Analysis Unravels the Molecular Basis of SARS Infection in Bronchoalveolar Stem Cells
Mallick, B., Ghosh, Z., & Chakrabarti, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007837 · Cited by 122
Ma, Y., Yang, J., Fan, X., Zhao, H., Hu, W., Li, Z., Yu, G., Ding, X., Wang, J., Bo, X., et al. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01572.x · Cited by 116
Bandiera, S., Pernot, S., Saghire, H. E., Durand, S., Thumann, C., Crouchet, É., Ye, T., Fofana, I., Oudot, M. A., Barths, J., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00619-16 · Cited by 104
Emerging roles for RNA degradation in viral replication and antiviral defense
Abernathy, E., & Glaunsinger, B. A. (2015) · Virology · doi:10.1016/j.virol.2015.02.007 · Cited by 98
Severe Acute Respiratory Syndrome Coronavirus Gene 7 Products Contribute to Virus-Induced Apoptosis
Schaecher, S. R., Touchette, E., Schriewer, J. M., Buller, R. M. L., & Pekosz, A. S. (2007) · Journal of Virology · doi:10.1128/jvi.01266-07 · Cited by 82
Li, X., Fu, Z., Liang, H., Wang, Y., Qi, X., Ding, M., Sun, X., Zhou, Z., Huang, Y., Gu, H., et al. (2018) · Cell Research · doi:10.1038/cr.2018.3 · Cited by 79
McCaskill, J. L., Ressel, S., Alber, A., Redford, J., Power, U. F., Schwarze, J., Dutia, B. M., & Buck, A. H. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.03.008 · Cited by 69
Identification of Ebola virus microRNAs and their putative pathological function
Liang, H., Zhou, Z., Zhang, S., Zen, K., Chen, X., & Zhang, C. (2014) · Science China Life Sciences · doi:10.1007/s11427-014-4759-2 · Cited by 63
Ye, R., Montalto-Morrison, C., & Masters, P. S. (2004) · Journal of Virology · doi:10.1128/jvi.78.18.9904-9917.2004 · Cited by 59
On the performance of pre-microRNA detection algorithms
Demirci, M. D. S., Baumbach, J., & Allmer, J. (2017) · Nature Communications · doi:10.1038/s41467-017-00403-z · Cited by 58
Zhang, S., Li, J., Li, J., Yang, Y., Kang, X., Li, Y., Wu, X., Zhu, Q., Zhou, Y., & Hu, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-25073-9 · Cited by 51
Herbert, K. M., & Nag, A. (2016) · Viruses · doi:10.3390/v8060154 · Cited by 35
The Battle of RNA Synthesis: Virus versus Host
Harwig, A., Landick, R. C., & Berkhout, B. (2017) · Viruses · doi:10.3390/v9100309 · Cited by 32
An overview of RNA virus-encoded microRNAs
Li, X., & Zou, X. (2019) · ExRNA · doi:10.1186/s41544-019-0037-6 · Cited by 31
Viral microRNAs Target a Gene Network, Inhibit STAT Activation, and Suppress Interferon Responses
Ramalingam, D., & Ziegelbauer, J. M. (2017) · Scientific Reports · doi:10.1038/srep40813 · Cited by 27
Welcome to our new Section Editors in INFECTION
Bogner, J. R. (2020) · Infection · doi:10.1007/s15010-019-01387-2 · Cited by 24
Huang, S., Lee, T.-Y., Lin, Y.-J., Wan, L., Lai, C., & Lin, C. (2015) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2015.07.002 · Cited by 23
miRNAs in enterovirus infection
Engelmann, I., Alidjinou, E. K., Bertin, A., Sané, F., & Hober, D. (2018) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2018.1499608 · Cited by 23
Viral MicroRNAs: Interfering the Interferon Signaling
Ahmad, I., Valverde, A. M., Siddiqui, H., Schaller, S. J., & Naqvi, A. R. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200109181238 · Cited by 22
Publisher Correction: Single-cell and spatial transcriptomics reveal somitogenesis in gastruloids
van den Brink, S., Alemany, A., van Batenburg, V., Moris, N., Blotenburg, M., Vivié, J., Baillie‐Johnson, P., Nichols, J., Sonnen, K. F., Arias, A. M., et al. (2020) · Nature · doi:10.1038/s41586-020-2113-3 · Cited by 20
Delineating the impact of machine learning elements in pre-microRNA detection
Demirci, M. D. S., & Allmer, J. (2017) · PeerJ · doi:10.7717/peerj.3131 · Cited by 18
Role of TAF4 in Transcriptional Activation by Rta of Epstein-Barr Virus
Yang, Y.-C., & Chang, L.-K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054075 · Cited by 12
A Machine Learning Approach for MicroRNA Precursor Prediction in Retro-transcribing Virus Genomes
Demirci, M. D. S., Toprak, M., & Allmer, J. (2016) · Berichte aus der medizinischen Informatik und Bioinformatik/Journal of integrative bioinformatics · doi:10.1515/jib-2016-303 · Cited by 9
Cited by
Sorted by citations
Noncoding RNA therapeutics—Challenges and potential solutions
Winkle, M., El-Daly, S. M., Fabbri, M., & Calin, G. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00219-z · Cited by 1,551
Blockchain and AI-Based Solutions to Combat Coronavirus (COVID-19)-Like Epidemics: A Survey
Nguyen, D. C., Ding, M., Pathirana, P. N., & Seneviratne, A. (2021) · IEEE Access · doi:10.1109/access.2021.3093633 · Cited by 286
Applications of artificial intelligence in COVID-19 pandemic: A comprehensive review
Khan, M., Mehran, M. T., Haq, Z. U., Ullah, Z., Naqvi, S. R., Ihsan, M., & Abbas, H. (2021) · Expert Systems with Applications · doi:10.1016/j.eswa.2021.115695 · Cited by 212
Emerging role of non‐coding RNA in health and disease
Bhatti, G. K., Khullar, N., Sidhu, I. S., Navik, U. S., Reddy, A. P., Reddy, P. H., & Bhatti, J. S. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00739-y · Cited by 192
Rahimi, A., Mirzazadeh, A., & Tavakolpour, S. (2020) · Genomics · doi:10.1016/j.ygeno.2020.09.059 · Cited by 180
Metadata
- Authors
- Saçar Demirci, M. D., & Adan, A.
- Affiliations
- Bioinformatics, Abdullah Gul University, Kayseri, Turkey
- Abdullah Gül University (TR)
- Venue
- PeerJ
- Publisher
- PeerJ
- Published
- 2020-06-05
- Volume
- 8
- Pages
- e9369
- ISSN
- 2167-8359 (ISSN-L)
- PMC
- PMC7278893
- OpenAlex
- W3033005856
- Cited by
- 190
- References
- 58
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 18 · 2023: 25 · 2022: 44 · 2021: 67 · 2020: 26
- FWCI
- 13.88
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PeerJ (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- SARS-CoV-2, microRNA, miRNA target prediction, host-virus interaction, Mediator complex, STAT1, viral proteins, miRNA-based therapy, post-transcriptional regulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
